Table 1 Number and percent of studies by funding source and regional setting (n = 400)
From: Ten years of implementation outcomes research: a scoping review
| Â | Number | % |
|---|---|---|
Funding | ||
 National Institutes of Health (US) | 99 | 24.5% |
 National Institute of Mental Health | 53 | 13.3% |
 National Institute on Drug Abuse | 21 | 5.3% |
 National Cancer Institute | 14 | 3.5% |
 National Heart, Lung, and Blood Institute | 5 | 1.3% |
 National Institute of Child Health & Human Development | 6 | 1.5% |
 Non-US | 103 | 25.8% |
 Other US Federal | 66 | 16.5% |
 None noted/specified | 59 | 14.8% |
 Other Foundation | 44 | 11.0% |
 US Veterans’ Administration | 9 | 2.3% |
 Agency for Healthcare Research and Quality (US) | 9 | 2.3% |
 US State Funding | 5 | 1.3% |
 Patient-Centered Outcomes Research Institute (US) | 3 | 0.8% |
 Industry | 2 | 0.5% |
Region | ||
 Africa | 40 | 10.0% |
 Asia | 17 | 4.3% |
 Australia | 18 | 4.5% |
 Canada | 26 | 6.5% |
 Caribbean | 3 | 0.8% |
 Central America | 7 | 1.8% |
 Europe | 65 | 16.3% |
 Middle East | 1 | 0.3% |
 Not specified | 3 | 0.8% |
 South America | 6 | 1.5% |
 USA | 227 | 56.8% |